Nocturnal nondipping and left ventricular hypertrophy in hypertension: an updated review

Cesare Cuspidi1, Valentina Giudici, Francesca Negri

  • 1Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Milano, Italy. cesare.cuspidi@unmib.it

Insights

Nondipping blood pressure status, characterized by a reduced nocturnal BP fall, is linked to left ventricular hypertrophy (LVH) in hypertensive individuals. Persistent nondipping patterns suggest more significant cardiac involvement, though regression remains unproven.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Circadian Biology

Background:

  • Circadian blood pressure (BP) variations, specifically dipping versus nondipping patterns, aid in risk stratification and treatment decisions for hypertensive patients.
  • A reduced nocturnal BP fall (nondipping) is increasingly associated with cardiovascular complications, though its link to left ventricular hypertrophy (LVH) is debated.

Purpose of the Study:

  • To review and analyze studies published in the last decade (2000-2009) investigating the association between nondipping status and left ventricular hypertrophy (LVH).
  • To examine the therapeutic implications of this association in hypertensive individuals.

Main Methods:

  • A PubMed search was conducted for full-text English articles published between January 1, 2000, and December 31, 2009.
  • Studies included adult or elderly subjects diagnosed with hypertension.
  • Twenty-six studies involving 3877 participants met the selection criteria.

Main Results:

  • Out of 26 selected studies, 17 (2497 participants) found a positive association between nondipping and LVH, while 9 studies reported no significant link.
  • Three studies using consistent ambulatory blood pressure monitoring confirmed a significant association between persistent nondipping and LVH.
  • Preliminary evidence suggests that nondipping may be reversible with chronotherapy or diuretics in salt-sensitive patients.

Conclusions:

  • A significant number of studies indicate an association between nondipping blood pressure patterns and left ventricular hypertrophy in hypertensive individuals.
  • Persistent nondipping, confirmed by rigorous monitoring, appears more strongly linked to cardiac involvement.
  • While potential therapeutic strategies exist, the regression of cardiac damage by restoring normal nocturnal BP dips in hypertensive patients with LVH requires further investigation.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...